JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $60 Price Target
Portfolio Pulse from richadhand@benzinga.com
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on OrthoPediatrics (NASDAQ:KIDS) and maintained a $60 price target.
August 01, 2023 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics' stock rating has been reiterated as Market Outperform by JMP Securities, with a maintained price target of $60.
The reiteration of the Market Outperform rating and the maintained price target by JMP Securities indicates a positive outlook for OrthoPediatrics. This could potentially attract investors and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100